日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Ligand-activated EGFR/MAPK signaling but not PI3K, are key resistance mechanisms to EGFR-therapy in colorectal cancer.

配体激活的 EGFR/MAPK 信号通路(而非 PI3K)是结直肠癌中 EGFR 疗法产生耐药性的关键机制

Qu Xueping, Hamidi Habib, Johnson Radia M, Sokol Ethan S, Lin Eva, Eng Cathy, Kim Tae Won, Bendell Johanna, Sivakumar Smruthy, Kaplan Benjamin, de Sousa E Melo Felipe, Mancini Andrew, Wongchenko Matthew, Shi Yi, Shames David, Yan Yibing, Ciardiello Fortunato, Bais Carlos

First Results of Migoprotafib, a Potent and Highly Selective Src Homology-2 Domain-Containing Phosphatase 2 Inhibitor in Patients with Advanced Solid Tumors

Migoprotafib(一种强效且高选择性的含Src同源-2结构域的磷酸酶2抑制剂)在晚期实体瘤患者中的初步疗效

Johnson, Melissa L; Wolf, Beni B; Wang, Judy S; Philipovskiy, Alexander; Shapiro, Geoffrey I; Bockorny, Bruno; Guo, Wei; Shen, Jinshan; Jen, Kai Yu; LeRose, MaryBeth; Hunter, Tamieka Lauz; Padval, Mahesh; Schmidt-Kittler, Oleg; Bhatia, Namrata; Dubey, Sarita; Suchomel, Julia; Bendell, Johanna C; Jauhari, Shekeab; Eng-Wong, Jennifer; Lin, Jessica J

Acute transcutaneous CO(2) exposure: A feasibility study for the future investigation of CO(2)-specific exercise adaptations

急性经皮二氧化碳暴露:一项可行性研究,旨在为未来研究二氧化碳特异性运动适应性提供参考

Thompson, Kyle M A; Bendell, Avery; Burr, Jamie F

Artificial social intelligence in teamwork: how team traits influence human-AI dynamics in complex tasks

人工智能在团队合作中的社交应用:团队特征如何影响复杂任务中人机互动

Bendell, Rhyse; Williams, Jessica; Fiore, Stephen M; Jentsch, Florian

A phase 1 study of the CD40 agonist MEDI5083 in combination with durvalumab in patients with advanced solid tumors

CD40激动剂MEDI5083联合度伐利尤单抗治疗晚期实体瘤患者的I期研究

Tran, Ben; Voskoboynik, Mark; Bendell, Johanna; Gutierrez, Martin; Lemech, Charlotte; Day, Daphne; Frentzas, Sophia; Garrido-Laguna, Ignacio; Standifer, Nathan; Wang, Fujun; Ferte, Charles; Wang, Yue; Das, Mayukh; Carneiro, Benedito A

Anti-TIGIT Antibody Tiragolumab Alone or With Atezolizumab in Patients With Advanced Solid Tumors: A Phase 1a/1b Nonrandomized Controlled Trial

抗TIGIT抗体Tiragolumab单药或联合Atezolizumab治疗晚期实体瘤患者:一项1a/1b期非随机对照试验

Kim, Tae Won; Bedard, Philippe L; LoRusso, Patricia; Gordon, Michael S; Bendell, Johanna; Oh, Do-Youn; Ahn, Myung-Ju; Garralda, Elena; D'Angelo, Sandra P; Desai, Jayesh; Hodi, F Stephen; Wainberg, Zev; Delord, Jean-Pierre; Cassier, Phillippe A; Cervantes, Andrés; Gil-Martin, Marta; Wu, Benjamin; Patil, Namrata S; Jin, Yanling; Hoang, Tien; Mendus, Diana; Wen, Xiaohui; Meng, Raymond; Cho, Byoung Chul

Tumor-intrinsic expression of the autophagy gene Atg16l1 suppresses anti-tumor immunity in colorectal cancer

肿瘤细胞内自噬基因Atg16l1的表达抑制结直肠癌的抗肿瘤免疫

Lucia Taraborrelli # ,Yasin Şenbabaoğlu # ,Lifen Wang # ,Junghyun Lim ,Kerrigan Blake ,Noelyn Kljavin ,Sarah Gierke ,Alexis Scherl ,James Ziai ,Erin McNamara ,Mark Owyong ,Shilpa Rao ,Aslihan Karabacak Calviello ,Daniel Oreper ,Suchit Jhunjhunwala ,Guillem Argiles ,Johanna Bendell ,Tae Won Kim ,Fortunato Ciardiello ,Matthew J Wongchenko ,Frederic J de Sauvage ,Felipe de Sousa E Melo ,Yibing Yan ,Nathaniel R West ,Aditya Murthy

Phase I/II sequencing study of azacitidine, epacadostat, and pembrolizumab in advanced solid tumors

阿扎胞苷、依帕卡司他和帕博利珠单抗治疗晚期实体肿瘤的 I/II 期测序研究

Jason J Luke, Marwan Fakih, Charles Schneider, E Gabriela Chiorean, Johanna Bendell, Rebecca Kristeleit, Razelle Kurzrock, Sarah P Blagden, Irene Brana, Laura W Goff, Kevin O'Hayer, Ryan Geschwindt, Michael Smith, Feng Zhou, Aung Naing2

First-in-human study of oleclumab, a potent, selective anti-CD73 monoclonal antibody, alone or in combination with durvalumab in patients with advanced solid tumors

首次人体研究评估了强效、选择性抗CD73单克隆抗体oleclumab单独使用或与durvalumab联合使用治疗晚期实体瘤患者的疗效。

Bendell, Johanna; LoRusso, Patricia; Overman, Michael; Noonan, Anne M; Kim, Dong-Wan; Strickler, John H; Kim, Sang-We; Clarke, Stephen; George, Thomas J; Grimison, Peter S; Barve, Minal; Amin, Manik; Desai, Jayesh; Wise-Draper, Trisha; Eck, Steven; Jiang, Yu; Khan, Anis A; Wu, Yuling; Martin, Philip; Cooper, Zachary A; Elgeioushi, Nairouz; Mueller, Nancy; Kumar, Rakesh; Patel, Sandip Pravin

Predictive potential of angiopoietin-2 in a mCRC subpopulation treated with vanucizumab in the McCAVE trial

在McCAVE试验中,血管生成素-2在接受vanucizumab治疗的mCRC亚群中的预测潜力

Ferreira, Cláudia S; Babitzki, Galina; Klaman, Irina; Krieter, Oliver; Lechner, Katharina; Bendell, Johanna; Vega Harring, Suzana; Heil, Florian